Biosketch Mafalda Oliveira

Mafalda Oliveira
Current position
Curriculum Summary

Mafalda Oliveira MD, PhD, is a medical oncologist at the Medical Department of the Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO) in Barcelona since 2011. She has completed a Master in Clinical Research in June 2013 and a PhD in Medicine in July 2017, both at the Universidad Autònoma de Barcelona.

Dr. Oliveira’s research interest focuses on the study of the molecular alterations and evolution of metastatic breast cancer, the clinical development of new drugs (especially by designing clinical trials with innovative biological hypotheses), and on the application of liquid biopsies as diagnostic, predictive, and prognostic tools in breast cancer. She is involved as Principal Investigator in multiple phase I, phase II, and phase III clinical trials in breast cancer, with drugs that target the PI3K/AKT/mTOR pathway, CDK4/6 inhibitors, oral SERDs, new epigenetic drugs, ADCs, and cancer immunotherapy drugs.

She is also a member of the Executive Board and the Scientific Committee of SOLTI-Breast Cancer Research Group (an academic cooperative research group based in Spain), and a member of ASCO, ESMO, SEOM, and AACR.